CTA
Carillon Tower Advisers Portfolio holdings
AUM
$16.4B
1-Year Return
64.74%
This Quarter Return
+8.98%
1 Year Return
+64.74%
3 Year Return
+147.29%
5 Year Return
–
10 Year Return
–
AUM
$9.4M
AUM Growth
–
Cap. Flow
+$9.4M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
19.15%
Holding
297
New
297
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Prestige Consumer Healthcare
PBH
|
$404K |
| 2 |
FibroGen
FGEN
|
$282K |
| 3 |
COHR
Coherent Inc
COHR
|
$213K |
| 4 |
Waste Connections
WCN
|
$146K |
| 5 |
ULTI
Ultimate Software Group Inc
ULTI
|
$137K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 25.41% |
| 2 | Technology | 19.12% |
| 3 | Industrials | 15.58% |
| 4 | Consumer Discretionary | 12.66% |
| 5 | Financials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Puma Biotechnology
PBYI
$253M
| $20.5K | 0.22% |
+207,820
| New | +$20.5K |
|
177
AT&T
T
$212B
| $20.1K | 0.21% |
+685,226
| New | +$20.1K |
|
178
Allegion
ALLE
$14.8B
| $19.7K | 0.21% |
+248,058
| New | +$19.7K |
|
179
Coca-Cola
KO
$292B
| $19.2K | 0.2% |
+419,503
| New | +$19.2K |
|
180
Chevron
CVX
$310B
| $19.2K | 0.2% |
+153,728
| New | +$19.2K |
|
181
Incyte
INCY
$16.9B
| $19K | 0.2% |
+200,185
| New | +$19K |
|
|
BHVN
182
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $18.6K | 0.2% |
+690,417
| New | +$18.6K |
|
183
Cisco
CSCO
$264B
| $18.4K | 0.2% |
+479,266
| New | +$18.4K |
|
184
Wells Fargo
WFC
$253B
| $18K | 0.19% |
+296,892
| New | +$18K |
|
185
Union Pacific
UNP
$131B
| $17.9K | 0.19% |
+133,501
| New | +$17.9K |
|
|
INFN
186
DELISTED
Infinera Corporation Common Stock
INFN
| $17.5K | 0.19% |
+2,768,997
| New | +$17.5K |
|
187
Altria Group
MO
$112B
| $16.9K | 0.18% |
+236,030
| New | +$16.9K |
|
188
TotalEnergies
TTE
$133B
| $16.8K | 0.18% |
+304,174
| New | +$16.8K |
|
189
Occidental Petroleum
OXY
$45.2B
| $16.7K | 0.18% |
+227,379
| New | +$16.7K |
|
190
PepsiCo
PEP
$200B
| $16.5K | 0.18% |
+137,568
| New | +$16.5K |
|
191
3M
MMM
$82.7B
| $15.7K | 0.17% |
+79,637
| New | +$15.7K |
|
192
DuPont de Nemours
DD
$32.6B
| $15.3K | 0.16% |
+106,645
| New | +$15.3K |
|
|
MDCO
193
DELISTED
Medicines Co
MDCO
| $15.3K | 0.16% |
+558,810
| New | +$15.3K |
|
|
ALDR
194
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $14.7K | 0.16% |
+1,281,760
| New | +$14.7K |
|
195
Procter & Gamble
PG
$375B
| $14.5K | 0.15% |
+158,140
| New | +$14.5K |
|
|
PTHN
196
DELISTED
Patheon N.V.
PTHN
| $14.5K | 0.15% |
+421,338
| New | +$14.5K |
|
197
McDonald's
MCD
$224B
| $14K | 0.15% |
+81,079
| New | +$14K |
|
198
Merck
MRK
$212B
| $13.8K | 0.15% |
+257,788
| New | +$13.8K |
|
199
Abbott
ABT
$231B
| $13.8K | 0.15% |
+242,099
| New | +$13.8K |
|
200
Merit Medical Systems
MMSI
$5.51B
| $13.8K | 0.15% |
+874,711
| New | +$13.8K |
|